Cheminant, M., Bruneau, J., Malamut, G., Sibon, D., Guegan, N., van Gils, T., Cording, S., Trinquand, A., Verkarre, V., Lhermitte, L., Brousse, N., Jannot, A., Khater, S., Frenzel, L., Delarue, R., Suarez, F., Marçais, A., Mulder, C. J., Macintyre, E., Asnafi, V., Pouyet, L., Bonnafous, C., Lhospice, F., Molina, T. J., Meresse, B., Cellier, C., Cerf-Bensussan, N., & Hermine, O. (2019). nKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study. Gut, 68(8), 1396–1405. http://access.bl.uk/ark:/81055/vdc_100135149174.0x000041